222 related articles for article (PubMed ID: 24308577)
1. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
Linhares AC; Justino MC
Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
[TBL] [Abstract][Full Text] [Related]
2. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus vaccines: a story of success.
Kollaritsch H; Kundi M; Giaquinto C; Paulke-Korinek M
Clin Microbiol Infect; 2015 Aug; 21(8):735-43. PubMed ID: 25680314
[TBL] [Abstract][Full Text] [Related]
4. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus vaccination: a concise review.
Vesikari T
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
[TBL] [Abstract][Full Text] [Related]
7. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil.
Fernandes EG; Sato HK; Leshem E; Flannery B; Konstantyner TC; Veras MA; Patel MM
Vaccine; 2014 Jun; 32(27):3402-8. PubMed ID: 24736002
[TBL] [Abstract][Full Text] [Related]
8. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
Lloyd-Johnsen C; Justice F; Donath S; Bines JE
Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
[TBL] [Abstract][Full Text] [Related]
10. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
[TBL] [Abstract][Full Text] [Related]
12. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.
Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ
Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174
[TBL] [Abstract][Full Text] [Related]
13. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccines in Belgium: policy and impact.
Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccination in Central American children.
Ulloa-Gutierrez R; Avila-Aguero ML
Expert Rev Vaccines; 2014 Jun; 13(6):687-90. PubMed ID: 24702467
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
[TBL] [Abstract][Full Text] [Related]
17. A benefit-risk analysis of rotavirus vaccination, France, 2015.
Lamrani A; Tubert-Bitter P; Hill C; Escolano S
Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644
[TBL] [Abstract][Full Text] [Related]
18. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
[TBL] [Abstract][Full Text] [Related]
19. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.
Paulke-Korinek M; Kollaritsch H; Aberle SW; Zwazl I; Schmidle-Loss B; Vécsei A; Kundi M
Vaccine; 2013 May; 31(24):2686-91. PubMed ID: 23597718
[TBL] [Abstract][Full Text] [Related]
20. Potential intussusception risk versus benefits of rotavirus vaccination in the United States.
Desai R; Cortese MM; Meltzer MI; Shankar M; Tate JE; Yen C; Patel MM; Parashar UD
Pediatr Infect Dis J; 2013 Jan; 32(1):1-7. PubMed ID: 22929172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
